ITE TL 2022-23 Flashcards
Blood:gas coefficient
ratio of gas dissolved in the blood and the alveoli at equilibrium
-larger -> higher solubility in blood -> slower onsent of action
second gas effect
rapid uptake of nitrous oxide into the blood -> second gas inc in conc due to loss of volume of nitrous oxide -> more rapid uptaek of 2nd inhaled anesthetic (more concentrated)
B:G coefficient Des, iso, Nitrous oxide, sevo
Des: 0.42
Nitrous: 0.46
Sevo: 0.65
Iso: 1.46
Vecuronium metabolism
metab by liver w/ byproduct w/ 80% potency -> metabolite (3-desacetyl-vercuronium) can build up in pts w/ renal insuff or liver failure
Vecuronium onset/duration
onset: 3-4 minutes, duration: 25-50 minutes
Pancuronium metab
Active metabolite -> build up in hepatic/renal failure -> prolongation of NMB
Cisatracurium metabolism
Hofmann elimination and ester hydrolysis (spontaneous degradation in plasma) -> inactive metabolite
Mivacurium metabolism
metabolized by pseudocholinesterases into inactive metabolites
Rocuronium metabolism
excreted unchanged by biliary and renal systems
-small amount metabolized by liver -> 17-OH roc -> minimal NMB activity
Potentiating NMB w/ inhalational gases, which the most?
DES!
Des > Sevo > Iso > nitrous oxide
Does that gas potentiate the NMB? Yes it DES!
Perip fluid management peds
Healthy peds pts elective surgery: 20-40 cc/kg over 2-4 hours LR,NS, plasmalyte
12 hrs post-op: 2-1.05 cc/kg/hr if not tolerating PO
When to use glucose containing solutions in peds
neonates, infants <6 months old, malnourished children, undergoing cardiac solution 1-2.5% dextrose
-be sure to monitor glucose!
Digoxin MOA
Glycoside -> positive ionotropic and negative dromotropic and chronotropic effects
-inc myocardial contractility, inc phase 4 depolarizations, and shortens action potential
-dec AV node conduction velocity, and prolongs refractory period of AV node
Digoxin toxicity symptoms
nausea, vomiting, diarrhea, abd pain
-vision changes yellow -> green, blurry vision,
=vent tachyarrythmias, and atrial tachycardia w/ AV block
-EKG: ST depressions, dec QT interval, inc PR interval, T wave inversions (normal w/ digoxin, not necessarily toxicity)
Digoxin toxicity inc risk
advanced age, worsening renal function, hypokalemia, low body weight, med noncompliance
beta-blocker toxicity
bradycardia, hypotension, hypoglycemia, hyperkalemia, wheezing,
severe: sz, deliriuum, and coma
PONV guidelines
-if any risk factor -> multimodal ppx
-RF: female, hx of PONV or motion sickness, postop opioids, non-smoker
-volatile anesthetics, nitrous, GA, long duration, young, gastric, gyn, or laparoscopic surgery
-1-2 RF: 2 interventions
-3-4 RF: 3-4 interventions
Jugular bulb venous O2 saturation monitoring
-put a catheter in retrograde and measure mixed venous sats at the jugular venous bulb
-measure of GLOBAL cerebral oxygenation, not local
(no change in stroke b/c local ischemia)
global cerebral oxygen supply and demand
supply: CBF, arterial oxygen content, and Hgb
demand: CMRO2
Cardiac myocyte action potential phases
phase 0: Depolarization
-VG Na channels open -> influx of + Na => membrane -90 to +20
phase 1: early rapid repolarization
-Na channel inactive, K ions exit cell -> dec in membrane potential
phase 2: plateau
-Ca active, Ca moves intracellularly, balancing out K leaving -> slows rate of decline in AP
phase 3: repolarization
-Ca inactive, K permeability inc -> AP decline
phase 4: resting potential
-normal cell permeability restored, Na-K-ATPase pumps K in and Na out
post-heart transplant heart
Denervated -> isolated from recipient nervous system
-only resp to direct myocardial adrenergic -> isoproterenol, epi, dob
-no resp to atropine, no resp to hypovolemia, no reflex for phenylephrine
-resting HR: 90-110
-accelerated rate of atherosclerotic disease
-no angina b/c denervated
tingling lateral surface of lower leg and dorsum of feet and toes, weakness w/ eversion of foot, what n?
Common peroneal nerve
-likely due to lithotomy position -> to dec minimize pressure at fibular head
Tramadol metabolism
PRO-DRUG
-metab by cytochrome p450 2D6 and 3A4
Tramadol MOA
After metabolism (pro-drug)
+ enantiomer: mu opiod agonist
- enantiomer: SNRI ( serotonin and NE reuptake inh)